Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm, Residual × acalabrutinib × 90 days × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 19 Lymphoma, Mantle-Cell 9 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma, Non-Hodgkin 2 Lymphoma, B-Cell 2 Lymphoma 2 Leukemia, B-Cell 2 Waldenstrom Macroglobulinemia 1 Recurrence 1 Pyloric Stenosis, Hypertrophic 1 Lymphatic Diseases 1 Leukemia, Prolymphocytic 1 Leukemia 1 Heart Failure 1 Glioblastoma 1 Chromosome 17 deletion 1

Interventions

Cyclophosphamide 5 fludarabine 4 Dexamethasone 4 blinatumomab 3 Lenalidomide 3 pembrolizumab 2 fludarabine phosphate 2 Cytarabine 2 venetoclax 1 tislelizumab 1 tisagenlecleucel 1 tetrathiomolybdate 1 tagraxofusp 1 relugolix 1 obinutuzumab 1 nilotinib 1 ixazomib 1 isatuximab 1 inavolisib 1 giredestrant 1 enzalutamide 1 daratumumab 1 abemaciclib 1 Vincristine 1 Transplantation 1 Radiotherapy 1 Neoadjuvant Therapy 1 Monatide (IMS 3015) 1 Methotrexate 1 Melphalan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡